The post ‘High Potential’ Season 2 Just Broke A 26-Year TV Record appeared on BitcoinEthereumNews.com. While High Potential is obviously a hit on ABC, what level of hit is something else entirely. ABC has not just said it’s the fall’s #1 broadcast entertainment series in live+7 day viewing, but it’s set a literal record that has stood for 26 years. High Potential season 2 represents the first time that a 10 PM drama has led these rankings since 1999, when ER did the same. It squeezed this record in before CBS is launches a bunch of shows this month, but hey, it counts. High Potential has a stunning 98% Rotten Tomatoes score across 2 seasons now, and the first half of season 2 ends in just a few days on October 28. It’s currently up 29% in viewers year over year as word of mouth has spread about the crime-solving series starring It’s Always Sunny in Philadelphia’s Kaitlin Olson. Here’s the synopsis: “Morgan, a single mom with three kids and an exceptional mind, helps solve an unsolvable crime when she rearranges some evidence during her shift as a cleaner for the police department. When they discover she has a knack for putting things in order because of her high intellectual potential, she is brought on as a consultant to work with a by-the-book seasoned detective, Karadec. Together they form an unusual and unstoppable team.” Sure, smart detective notices things other people don’t is not the newest concept, here with Olson it works better than most of the rest, hence the high scores and big viewership numbers. It feels like a show shooting for at least five seasons or more already, even with season 2 only halfway over. While these records are about ABC network viewing, High Potential also airs on Hulu and Disney+, where it’s currently the #1 show on both services. High Potential is… The post ‘High Potential’ Season 2 Just Broke A 26-Year TV Record appeared on BitcoinEthereumNews.com. While High Potential is obviously a hit on ABC, what level of hit is something else entirely. ABC has not just said it’s the fall’s #1 broadcast entertainment series in live+7 day viewing, but it’s set a literal record that has stood for 26 years. High Potential season 2 represents the first time that a 10 PM drama has led these rankings since 1999, when ER did the same. It squeezed this record in before CBS is launches a bunch of shows this month, but hey, it counts. High Potential has a stunning 98% Rotten Tomatoes score across 2 seasons now, and the first half of season 2 ends in just a few days on October 28. It’s currently up 29% in viewers year over year as word of mouth has spread about the crime-solving series starring It’s Always Sunny in Philadelphia’s Kaitlin Olson. Here’s the synopsis: “Morgan, a single mom with three kids and an exceptional mind, helps solve an unsolvable crime when she rearranges some evidence during her shift as a cleaner for the police department. When they discover she has a knack for putting things in order because of her high intellectual potential, she is brought on as a consultant to work with a by-the-book seasoned detective, Karadec. Together they form an unusual and unstoppable team.” Sure, smart detective notices things other people don’t is not the newest concept, here with Olson it works better than most of the rest, hence the high scores and big viewership numbers. It feels like a show shooting for at least five seasons or more already, even with season 2 only halfway over. While these records are about ABC network viewing, High Potential also airs on Hulu and Disney+, where it’s currently the #1 show on both services. High Potential is…

‘High Potential’ Season 2 Just Broke A 26-Year TV Record

For feedback or concerns regarding this content, please contact us at [email protected]

While High Potential is obviously a hit on ABC, what level of hit is something else entirely. ABC has not just said it’s the fall’s #1 broadcast entertainment series in live+7 day viewing, but it’s set a literal record that has stood for 26 years.

High Potential season 2 represents the first time that a 10 PM drama has led these rankings since 1999, when ER did the same. It squeezed this record in before CBS is launches a bunch of shows this month, but hey, it counts.

High Potential has a stunning 98% Rotten Tomatoes score across 2 seasons now, and the first half of season 2 ends in just a few days on October 28. It’s currently up 29% in viewers year over year as word of mouth has spread about the crime-solving series starring It’s Always Sunny in Philadelphia’s Kaitlin Olson. Here’s the synopsis:

Sure, smart detective notices things other people don’t is not the newest concept, here with Olson it works better than most of the rest, hence the high scores and big viewership numbers. It feels like a show shooting for at least five seasons or more already, even with season 2 only halfway over.

While these records are about ABC network viewing, High Potential also airs on Hulu and Disney+, where it’s currently the #1 show on both services. High Potential is also a flashback to “normal TV,” where the two seasons aired exactly a year apart. Season 1 had 13 episodes, and season 2 had 18. This is, no doubt, because it’s a broadcast show, but we see neither of these things in the streaming space practically ever, and I have to believe it’s another aspect that’s helped it catch on. I cannot find when season 2, part 2 airs, as I don’t think that it’s been announced yet. Season 1 indicates it may be in January 2026.

So, if you’ve missed out on the show so far, it may be time to catch up. My wife has been watching it for a while now, and so I’ve only been vaguely aware of it, as I haven’t been paying attention. Maybe it’s time to start.

Follow me on Twitter, YouTube, Bluesky and Instagram.

Pick up my sci-fi novels the Herokiller series and The Earthborn Trilogy.

Source: https://www.forbes.com/sites/paultassi/2025/10/24/high-potential-season-2-just-broke-a-26-year-tv-record/

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0.0003689
$0.0003689$0.0003689
+2.44%
USD
Notcoin (NOT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09